Syra Health To Discuss Second Quarter 2024 Financial Results
Rhea-AI Summary
Syra Health Corp. (NASDAQ: SYRA), a healthcare technology company, has announced its plans to report financial results for the second quarter of 2024 on Thursday, August 8, 2024, before the market opens. The company will host a conference call at 9:00 AM ET on the same day to discuss the results.
Investors can access the conference call via an Internet webcast available on the company's website. Those wishing to submit questions for the call can email them to shamsian@lythampartners.com. A replay of the webcast will be available in the Investors section of Syra Health's website after the call.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, SYRA gained 3.79%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Conference call will be held on Thursday, August 8 at 9:00 AM ET
Interested parties can access the conference call via Internet webcast, which is available in the Investors section of the Company's website at http://www.syrahealth.com/ir/presentations/q2-2024-earnings-call.
Investors who would like to submit a question to be addressed on the call should email the question to shamsian@lythampartners.com.
A webcast replay will be available in the Investors section of the Company's website at http://www.syrahealth.com/ir/presentations/q2-2024-earnings-call.
ABOUT SYRA HEALTH
Syra Health is a healthcare technology company powering better health in challenging areas such as behavioral and mental health, digital health, and population health, by providing innovative services and technology products. Syra Health's offerings are centered on prevention, improved access, and affordable care. Syra Health supplies its solutions to payers, providers, life sciences organizations, academic institutions, and the government. For more information, please visit www.syrahealth.com.
Contact
For Media Inquiries:
Christine Drury
Communications and Marketing Director
Syra Health
463-345-5180
christined@syrahealth.com
For Investor Inquiries:
Ben Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
shamsian@lythampartners.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/syra-health-to-discuss-second-quarter-2024-financial-results-302212436.html
SOURCE Syra Health